Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jarfandishan Navid Salamat is a prominent Iranian medical device manufacturer specializing in interventional cardiology products. As a key subsidiary of the Navid Salamat Group, the company is distinguished for developing and producing the first domestically manufactured drug-eluting stent (DES) in Iran, marketed under the brand name Siavash. Their product portfolio also includes PTCA balloon catheters and bare-metal stents, all produced in their specialized facility in Mashhad. The company is officially recognized as a knowledge-based enterprise, focusing on high-tech medical engineering to reduce the country's reliance on imported cardiovascular implants. Jarfandishan Navid Salamat adheres to international quality standards, including ISO 13485, to ensure the safety and efficacy of its life-saving medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jarfandishan-e Navid-e Salamat.